Razi Ebrahim, Moosavi Gholam Abbass, Razi Armin
Departments of Internal Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Tanaffos. 2012;11(2):16-21.
Due to current controversies regarding the effect of age on response to treatment in asthmatic patient, the present study was performed on patients referred with acute asthma attack for further evaluation of this matter.
In this study 138 patients with severe persistent asthma were enrolled and divided into two categories of young (age ≤35 yrs; 82 cases, mean age = 25.2±7.3 years) and elderly subjects (≥50 yrs; 56 cases, mean age 57.4±6.4 years). Response to treatment was determined by pulmonary function tests.
The mean percentage change of FEV1 from baseline in male and female patients of young and old age was 75.05±46.61 and 71.39±41.30%, (P = 0.721) and 100.79±51.34% and 69±37.39% (P = 0.015), respectively. The mean percentage of possible improvement of FEV1 among male and female patients of young and old age was 62.81±25.67% and 54.46±23.82% (P = 0.148), and 78±24.04% and 63.58±41.24% (P = 0.087); respectively.
Response to treatment was significant in both young and old age groups suffering from acute asthmatic attack except for young female patients in which, percentage change of FEV1 increased compared to older patients. Among other patients this value and percentage of possible improvement of FEV1 between the 2 groups did not change significantly and age did not play a significant role in assessing the response to treatment in acute asthmatic attack.
由于目前关于年龄对哮喘患者治疗反应的影响存在争议,本研究对因急性哮喘发作前来就诊的患者进行了进一步评估。
本研究纳入了138例重度持续性哮喘患者,分为年轻组(年龄≤35岁;82例,平均年龄=25.2±7.3岁)和老年组(≥50岁;56例,平均年龄57.4±6.4岁)。通过肺功能测试确定治疗反应。
年轻和老年男性及女性患者FEV1相对于基线的平均百分比变化分别为75.05±46.61%和71.39±41.30%(P = 0.721),以及100.79±51.34%和出69±37.39%(P = 0.015)。年轻和老年男性及女性患者FEV1可能改善的平均百分比分别为62.81±25.67%和54.46±23.82%(P = 0.148),以及78±24.04%和63.58±41.24%(P = 0.087)。
除年轻女性患者外,急性哮喘发作的年轻和老年组患者治疗反应均显著,年轻女性患者的FEV1百分比变化相比老年患者有所增加。在其他患者中,两组之间FEV1的这一数值及可能改善的百分比无显著变化,年龄在评估急性哮喘发作的治疗反应中不起显著作用。